Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment

Neuropharmacology

Volumn 62, Issue 1, 2012, Pages 304-312

  Sartori, S B ^a   Whittle, N ^a   Hetzenauer, A ^a   Singewald, N ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

ACTH; Anxiety; Corticotropin releasing hormone; Desipramine; Diazepam; Magnesium; Selective serotonin re uptake inhibitor; Stress axis

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; DIAZEPAM; PAROXETINE; PREPRO CORTICOTROPIN RELEASING HORMONE; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; BARRINGTON NUCLEUS; BEHAVIOR; BODY TEMPERATURE; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CHRONIC DRUG ADMINISTRATION; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; ELEVATED PLUS MAZE; EXPERIMENTAL MODEL; EXPERIMENTAL TEST; GENE EXPRESSION; HYPERTHERMIA; HYPONEOPHAGIA TEST; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIGHT DARK TEST; LOCOMOTION; MAGNESIUM DEFICIENCY; MALE; MAZE TEST; MOUSE; NERVE EXCITABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN FIELD TEST; PRIORITY JOURNAL; STRESS; STRESS INDUCED HYPERTHERMIA; TRANQUILIZING ACTIVITY; TRANSCRIPTION REGULATION; WEIGHT GAIN;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DARK ADAPTATION; DESIPRAMINE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEVER; FOOD DEPRIVATION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PAROXETINE; PITUITARY-ADRENAL SYSTEM; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RADIOIMMUNOASSAY; REACTION TIME; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 80054104942     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.07.027     Document Type: Conference Paper

References (80)

1. A. Aerni, R. Traber, C. Hock, B. Roozendaal, G. Schelling, A. Papassotiropoulos, R.M. Nitsch, U. Schnyder, and D.J. de Quervain Low-dose cortisol for symptoms of posttraumatic stress disorder Am. J. Psychiatry 161 2004 1488 1490 (Pubitemid 38989105)
2. P. Andlin-Sobocki, B. Jonsson, H.U. Wittchen, and J. Olesen Cost of disorders of the brain in Europe Eur. J. Neurol. 12 Suppl. 1 2005 1 27
3. D.J. Armstrong, G.K. Meenagh, I. Bickle, A.S. Lee, E.S. Curran, and M.B. Finch Vitamin D deficiency is associated with anxiety and depression in fibromyalgia Clin. Rheumatol. 26 2007 551 554 (Pubitemid 46359296)
4. D.G. Baker, S.A. West, W.E. Nicholson, N.N. Ekhator, J.W. Kasckow, K.K. Hill, A.B. Bruce, D.N. Orth, and T.D. Geracioti Jr. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder Am. J. Psychiatry 156 1999 585 588 (Pubitemid 29162980)
5. C.H. Beck, and H.C. Fibiger Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment J. Neurosci. 15 1995 709 720
6. C. Belzung Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms? Curr. Opin. Investig. Drugs 2 2001 1108 1111 (Pubitemid 32780713)
7. C. Belzung, and G. Griebel Measuring normal and pathological anxiety-like behaviour in mice: a review Behav. Brain Res. 125 2001 141 149 (Pubitemid 33000452)
8. D. Bentz, T. Michael, D.J. de Quervain, and F.H. Wilhelm Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications J. Anxiety Disord. 24 2010 223 230
9. S.R. Bodnoff, B. Suranyi-Cadotte, D.H. Aitken, R. Quirion, and M.J. Meaney The effects of chronic antidepressant treatment in an animal model of anxiety Psychopharmacology (Berl.) 95 1988 298 302
10. S.R. Bodnoff, B. Suranyi-Cadotte, R. Quirion, and M.J. Meaney A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety Psychopharmacology (Berl.) 97 1989 277 279 (Pubitemid 19040176)
11. O.J. Bosch, S.A. Kromer, and I.D. Neumann Prenatal stress: opposite effects on anxiety and hypothalamic expression of vasopressin and corticotropin-releasing hormone in rats selectively bred for high and low anxiety Eur. J. Neurosci. 23 2006 541 551
12. A. Bouwknecht, B. Olivier, and R.E. Paylor The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse Neurosci. Biobehav. Rev. 31 2007 41 59 (Pubitemid 44880072)
13. J.D. Bremner, J. Licinio, A. Darnell, J.H. Krystal, M.J. Owens, S.M. Southwick, C.B. Nemeroff, and D.S. Charney Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder Am. J. Psychiatry 154 1997 624 629 (Pubitemid 27197594)
14. P.L. Broadhurst Analysis of maternal effects in the inheritance of behavior Anim. Behav. 9 1961 129 141
15. P. Busquet, N. Khoi Nguyen, E. Schmid, N. Tanimoto, M.W. Seeliger, T. Ben-Yosef, F. Mizuno, A. Akopian, J. Striessnig, and N. Singewald CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype Int. J. Neuropsychopharmacol. 2009 1 15
16. D.S. Charney, and W.C. Drevets Neurobiological basis of anxiety disorders K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff, Neuropsychopharmacology - 5th Generation of Progress 2008 American College of Neuropsychopharmacology Nashville
17. A. Coppen, and C. Bolander-Gouaille Treatment of depression: time to consider folic acid and vitamin B12 J. Psychopharmacol. 19 2005 59 65
18. J.N. Crawley Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines Pharmacol. Biochem. Behav. 15 1981 695 699 (Pubitemid 12195249)
19. J.N. Crawley What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice 2000 Wiley-Liss
20. J.F. Cryan, and A. Holmes The ascent of mouse: advances in modelling human depression and anxiety Nat. Rev. Drug Discov. 4 2005 775 790 (Pubitemid 43090498)
21. M.A. de Medeiros, L. Carlos Reis, and L. Eugenio Mello Stress-induced c-Fos expression is differentially modulated by dexamethasone, diazepam and imipramine Neuropsychopharmacology 30 2005 1246 1256 (Pubitemid 40848079)
22. J.C. DeFries, J.P. Hegmann, and R.A. Halcomb Response to 20 generations of selection for open-field activity in mice Behav. Biol. 11 1974 481 495
23. S.C. Dulawa, and R. Hen Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test Neurosci. Biobehav. Rev. 29 2005 771 783 (Pubitemid 40762599)
24. S.C. Dulawa, K.A. Holick, B. Gundersen, and R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 2004 1321 1330 (Pubitemid 38780655)
25. M. German-Fattal, F. Lecerf, F. Sabbagh, P. Maurois, J. Durlach, and P. Bac Neuroprotective gene profile in the brain of magnesium-deficient mice Biomed. Pharmacother. 62 2008 264 272 (Pubitemid 351626448)
26. N. Gobshtis, S. Ben-Shabat, and E. Fride Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness Eur. J. Pharmacol. 554 2007 155 163 (Pubitemid 44879411)
27. J.A. Gordon, and R. Hen Genetic approaches to the study of anxiety Annu. Rev. Neurosci. 27 2004 193 222 (Pubitemid 39050402)
28. G. Griebel, C. Belzung, G. Perrault, and D.J. Sanger Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice Psychopharmacology (Berl.) 148 2000 164 170 (Pubitemid 30104138)
29. J.P. Guilloux, D.J. David, L. Xia, H.T. Nguyen, Q. Rainer, B.P. Guiard, C. Reperant, T. Deltheil, M. Toth, R. Hen, and A.M. Gardier Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments Neuropharmacology 61 2011 478 488
30. H. Hackbarth, N. Kuppers, and W. Bohnet Euthanasia of rats with carbon dioxide - animal welfare aspects Lab. Anim. 34 2000 91 96 (Pubitemid 30060266)
31. J.J. Haddad N-methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog. Neurobiol. 77 2005 252 282 (Pubitemid 41790443)
32. S. Hayashida, T. Oka, T. Mera, and S. Tsuji Repeated social defeat stress induces chronic hyperthermia in rats Physiol. Behav. 101 2010 124 131
33. K. Held, I.A. Antonijevic, H. Kunzel, M. Uhr, T.C. Wetter, I.C. Golly, A. Steiger, and H. Murck Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans Pharmacopsychiatry 35 2002 135 143 (Pubitemid 34876179)
34. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
35. T. Imaki, X.Q. Wang, T. Shibasaki, S. Harada, N. Chikada, C. Takahashi, M. Naruse, and H. Demura Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN) Brain Res. Mol. Brain Res. 32 1995 261 270
36. F.N. Jacka, S. Overland, R. Stewart, G.S. Tell, I. Bjelland, and A. Mykletun Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland health study Aust. N. Z. J. Psychiatry 43 2009 45 52
37. H. Jingami, N. Mizuno, H. Takahashi, S. Shibahara, Y. Furutani, H. Imura, and S. Numa Cloning and sequence analysis of cDNA for rat corticotropin- releasing factor precursor FEBS Lett. 191 1985 63 66 (Pubitemid 16234144)
38. K.M. Kantak Magnesium deficiency alters aggressive behavior and catecholamine function Behav. Neurosci. 102 1988 304 311
39. M.E. Keck, S.B. Sartori, T. Welt, M.B. Muller, F. Ohl, F. Holsboer, R. Landgraf, and N. Singewald Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment J. Neurochem. 92 2005 1170 1179 (Pubitemid 40344307)
40. C.E. Keegan, J.P. Herman, I.J. Karolyi, K.S. O'Shea, S.A. Camper, and A.F. Seasholtz Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain Endocrinology 134 1994 2547 2555 (Pubitemid 24170869)
41. A.J. Keeney, S. Hogg, and C.A. Marsden Alterations in core body temperature, locomotor activity, and corticosterone following acute and repeated social defeat of male NMRI mice Physiol. Behav. 74 2001 177 184 (Pubitemid 32879375)
42. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, and E.E. Walters Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication Arch. Gen. Psychiatry 62 2005 593 602 (Pubitemid 40973434)
43. J.L. Kroll New directions in the conceptualization of psychotic disorders Curr. Opin. Psychiatry 20 2007 573 577
44. S.A. Kromer, M.S. Kessler, D. Milfay, I.N. Birg, M. Bunck, L. Czibere, M. Panhuysen, B. Putz, J.M. Deussing, F. Holsboer, R. Landgraf, and C.W. Turck Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety J. Neurosci. 25 2005 4375 4384 (Pubitemid 40628782)
45. M.C. Laarakker, H.A. van Lith, and F. Ohl Behavioral characterization of A/J and C57BL/6J mice using a multidimensional test: association between blood plasma and brain magnesium-ion concentration with anxiety Physiol. Behav. 102 2011 205 219
46. A. Lecci, F. Borsini, G. Volterra, and A. Meli Pharmacological validation of a novel animal model of anticipatory anxiety in mice Psychopharmacology (Berl.) 101 1990 255 261 (Pubitemid 20140228)
47. M.R. Liebowitz Panic disorder as a chronic illness J. Clin. Psychiatry 58 Suppl. 13 1997 5 8
48. G. Liebsch, A.C. Linthorst, I.D. Neumann, J.M. Reul, F. Holsboer, and R. Landgraf Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior Neuropsychopharmacology 19 1998 381 396 (Pubitemid 28451594)
49. C.A. Lowry, and F.L. Moore Regulation of behavioral responses by corticotropin-releasing factor Gen. Comp. Endocrinol. 146 2006 19 27 (Pubitemid 43248703)
50. Z. Merali, C. Levac, and H. Anisman Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice Biol. Psychiatry 54 2003 552 565 (Pubitemid 37289442)
51. M.J. Millan The neurobiology and control of anxious states Prog. Neurobiol. 70 2003 83 244 (Pubitemid 37309295)
52. P. Muigg, S. Scheiber, P. Salchner, M. Bunck, R. Landgraf, and N. Singewald Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety PLoS One 4 2009 e5346
53. H. Murck Magnesium and affective disorders Nutr. Neurosci. 5 2002 375 389 (Pubitemid 35469537)
54. H. Murck, and A. Steiger Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men - possible therapeutic implications Psychopharmacology (Berl.) 137 1998 247 252 (Pubitemid 28277510)
55. A. Muroyama, M. Inaka, H. Matsushima, H. Sugino, Y. Marunaka, and Y. Mitsumoto Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice Neurosci. Res. 63 2009 72 75
56. N.K. Nguyen, S.B. Sartori, H. Herzog, R. Tasan, G. Sperk, and N. Singewald Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice Synapse 63 2009 236 246
57. C.M. O'Mahony, F.F. Sweeney, E. Daly, T.G. Dinan, and J.F. Cryan Restraint stress-induced brain activation patterns in two strains of mice differing in their anxiety behaviour Behav. Brain Res. 213 2010 148 154
58. K.B.L. Paxinos, and G. Franklin The Mouse Brain in Stereotaxic Coordinates second ed. 2001 Academic Press London
59. J. Plag, A. Siegmund, and A. Strohle Pharmakotherapie bei Angsterkrankungen Z. Psychiatr. Psychol. Psychother. 57 2009 185 194
60. E. Poleszak, B. Szewczyk, E. Kedzierska, P. Wlaz, A. Pilc, and G. Nowak Antidepressant- and anxiolytic-like activity of magnesium in mice Pharmacol. Biochem. Behav. 78 2004 7 12 (Pubitemid 38670508)
61. B.M. Popkin Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases Am. J. Clin. Nutr. 84 2006 289 298 (Pubitemid 44699136)
62. N. Salome, P. Salchner, O. Viltart, H. Sequeira, A. Wigger, R. Landgraf, and N. Singewald Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats Biol. Psychiatry 55 2004 715 723 (Pubitemid 38376183)
63. L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, N. Weisstaub, J. Lee, R. Duman, O. Arancio, C. Belzung, and R. Hen Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809 (Pubitemid 36962615)
64. S.B. Sartori, P.W. Burnet, T. Sharp, and N. Singewald Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain Neuropharmacology 46 2004 1177 1183 (Pubitemid 38529941)
65. S.B. Sartori, R. Landgraf, and N. Singewald The clinical implications of mouse models of enhanced anxiety Future Neurol 6 2011 531 571
66. M.S. Seelig Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review) J. Am. Coll. Nutr. 13 1994 429 446 (Pubitemid 24309975)
67. N. Singewald, P. Salchner, and T. Sharp Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs Biol. Psychiatry 53 2003 275 283 (Pubitemid 36175541)
68. N. Singewald, C. Sinner, A. Hetzenauer, S.B. Sartori, and H. Murck Magnesium-deficient diet alters depression- and anxiety-related behavior in mice - influence of desipramine and Hypericum perforatum extract Neuropharmacology 47 2004 1189 1197 (Pubitemid 39572710)
69. L.M. Soravia, M. Heinrichs, A. Aerni, C. Maroni, G. Schelling, U. Ehlert, B. Roozendaal, and D.J. de Quervain Glucocorticoids reduce phobic fear in humans Proc. Natl. Acad. Sci. U.S.A. 103 2006 5585 5590
70. S. Thys-Jacobs Micronutrients and the premenstrual syndrome: the case for calcium J. Am. Coll. Nutr. 19 2000 220 227 (Pubitemid 30185354)
71. A. Tschenett, N. Singewald, M. Carli, C. Balducci, P. Salchner, A. Vezzani, H. Herzog, and G. Sperk Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors Eur. J. Neurosci. 18 2003 143 148 (Pubitemid 36920855)
72. A.H. Veenema, O.C. Meijer, E.R. de Kloet, J.M. Koolhaas, and B.G. Bohus Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression Horm. Behav. 43 2003 197 204 (Pubitemid 36293290)
73. C.H. Vinkers, M.J. van Bogaert, M. Klanker, S.M. Korte, R. Oosting, T. Hanania, S.C. Hopkins, B. Olivier, and L. Groenink Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm Eur. J. Pharmacol. 585 2008 407 425
74. N. Whittle, L. Li, W.Q. Chen, J.W. Yang, S.B. Sartori, G. Lubec, and N. Singewald Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior Amino Acids 40 2011 1231 1248
75. N. Whittle, G. Lubec, and N. Singewald Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice Amino Acids 36 2009 147 158
76. WHO, 2004. Global burden of disease report.
77. I. Yalcin, F. Aksu, and C. Belzung Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol Eur. J. Pharmacol. 514 2005 165 174 (Pubitemid 40720357)
78. E.A. Young, J.L. Abelson, and I. Liberzon Stress hormones and anxiety disorders R.J. Blanchard, D.C. Blanchard, G. Griebel, D. Nutt, Handbook of Anxiety and Fear 2008 Academic Press Oxford 455 473
79. M.A. Zamorski, and R.C. Albucher What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder Am. Fam. Physician 66 2002 1477 1484 (Pubitemid 35402542)
80. R. Zender, and E. Olshansky Women's mental health: depression and anxiety Nurs. Clin. North Am. 44 2009 355 364